David_Flockhart

David Flockhart

David Flockhart

Scottish medical researcher

David A. Flockhart (1952–2015) was a Scottish medical researcher who was a leader in the field of personalised medicine.[1] He was especially known for his work on factors affecting the use of tamoxifen to treat breast cancer such as variability in the level of the CYP2D6 enzyme.[2][3]

References

  1. [1]
    "In death, there is life", The Economist, p. 84, 26 March 2016
  2. [2]
    "David Flockhart : Obituary", Edinburgh Evening News, 3 December 2015
  3. [3]
    In Memoriam, David A. Flockhart PhD, MD, Indiana University Department of Medicine, 26 November 2015


Stub icon

This biographical article related to medicine is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article David_Flockhart, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.